These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6832197)

  • 1. New aspects of the pharmacokinetics and pharmacodynamics of clonidine in man.
    Arndts D; Doevendans J; Kirsten R; Heintz B
    Eur J Clin Pharmacol; 1983; 24(1):21-30. PubMed ID: 6832197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New aspects of the clinical pharmacology of clonidine.
    Arndts D
    Chest; 1983 Feb; 83(2 Suppl):397-400. PubMed ID: 6822136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and side-effects of clonidine.
    Keränen A; Nykänen S; Taskinen J
    Eur J Clin Pharmacol; 1978 May; 13(2):97-101. PubMed ID: 658114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of oral sustained release clonidine in humans.
    MacGregor TR; Relihan GL; Keirns JJ
    Arzneimittelforschung; 1985; 35(1A):440-6. PubMed ID: 4039184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and concentration-effect relationships of intervenous and oral clonidine.
    Davies DS; Wing AM; Reid JL; Neill DM; Tippett P; Dollery CT
    Clin Pharmacol Ther; 1977 May; 21(5):593-601. PubMed ID: 870272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonidine kinetics in man--evidence for dose dependency and changed pharmacokinetics during chronic therapy.
    Frisk-Holmberg M; Paalzow L; Edlund PO
    Br J Clin Pharmacol; 1981 Nov; 12(5):653-8. PubMed ID: 7332729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of clonidine and its relation to the hypotensive effect in patients.
    Frisk-Holmberg M; Edlund PO; Paalzow L
    Br J Clin Pharmacol; 1978 Sep; 6(3):227-32. PubMed ID: 687501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of transdermally administered clonidine.
    Arndts D; Arndts K
    Eur J Clin Pharmacol; 1984; 26(1):79-85. PubMed ID: 6714294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of clonidine as transdermal therapeutic system: the international clinical trial experience.
    Lowenthal DT; Saris S; Paran E; Cristal N; Sharif K; Bies C; Fagan T
    Am Heart J; 1986 Oct; 112(4):893-900. PubMed ID: 3532747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and antihypertensive effects of low dose clonidine during chronic therapy.
    Anavekar SN; Howes LG; Jarrott B; Syrjanen M; Conway EL; Louis WJ
    J Clin Pharmacol; 1989 Apr; 29(4):321-6. PubMed ID: 2723120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics and pharmacokinetics of pinacidil after a single dose of a new slow release tablet in healthy volunteers.
    Bareggi SR; Gambaro V; Valenti M; Benvenuti C
    Arzneimittelforschung; 1998 Jul; 48(7):730-3. PubMed ID: 9706373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics of clonidine and chlorthalidone following subacute administration of a fixed combination compared with a sustained release formulation of clonidine alone (author's transl)].
    Arndts D; Doevendans J; Arendt G; Rippen G
    Arzneimittelforschung; 1981; 31(11):1954-7. PubMed ID: 7198476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic studies of oral clonidine in normotensive subjects.
    Anavekar SN; Jarrott B; Toscano M; Louis WJ
    Eur J Clin Pharmacol; 1982; 23(1):1-5. PubMed ID: 7128667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proof of the linearity of the pharmacokinetics of alinidine in man.
    Arndts D; Warnkross H; Rominger KL; Justus H
    Eur J Clin Pharmacol; 1981; 21(3):201-7. PubMed ID: 7318879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and relative bioavailability of vinylbital in man after oral and rectal administration.
    Breimer DD; de Boer AG
    Arzneimittelforschung; 1976; 26(3):448-54. PubMed ID: 989344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and concentration-effect relationships of clonidine in essential hypertension.
    Wing LM; Reid JL; Davies DS; Neill EA; Tippett P; Dollery CT
    Eur J Clin Pharmacol; 1977 Dec; 12(6):463-9. PubMed ID: 598422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of metabolic degradation on the blood pressure lowering effect of clonidine in rabbits after different routes of administration.
    Hoefke W; Darda S; Gaida W
    Arzneimittelforschung; 1985; 35(1A):401-5. PubMed ID: 4039177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of xamoterol after intravenous and oral administration to volunteers.
    Bastain W; Boyce MJ; Stafford LE; Morton PB; Clarke DA; Marlow HF
    Eur J Clin Pharmacol; 1988; 34(5):469-73. PubMed ID: 2904884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability and clinical effects of three brands of clonidine: the relationship between plasma level and effect.
    Kanto J; Allonen H; Hiltunen R; Marvola M; Mäntylä R
    Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):118-21. PubMed ID: 7068284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic properties of alinidine in man.
    Wiegand UW; Kasper W; Meinertz T; Stützle U; Jähnchen E
    J Cardiovasc Pharmacol; 1982; 4(1):59-62. PubMed ID: 6176801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.